Utah Vascular Center, Provo, Utah, USA.
J Vasc Surg. 2010 Jan;51(1):108-13. doi: 10.1016/j.jvs.2009.07.124. Epub 2009 Oct 30.
Catheter-associated upper extremity deep venous thrombosis (CAUEDVT) is well known; however, resolution rates and factors affecting resolution of CAUEDVT are not well characterized. This study determined resolution rates and factors associated with resolution of CAUEDVT.
From January 1, 2002, to June 30, 2006, 1761 upper extremity venous duplex ultrasound (DU) studies were performed, and a new UEDVT was found in 253 (14.4%). Of these, 150 patients had routine follow-up and 101 had CAUEDVT. Demographics, follow-up DU results, and risk factors for venous thrombosis were recorded in the patients with follow-up studies and CAUEDVT. Univariate analysis and multivariate logistic regression analysis was performed to determine independent risk factors for complete thrombus resolution.
There were 49 men (49%) and 52 women (51%) with CAUEDVT and follow-up studies. Mean age was 49 years (range, 5 months-80 years). Patients with CAUEDVT had risk factors for venous thrombosis that included malignancy in 34%, recent surgery/trauma in 34%, known hypercoagulable state in 11%, concomitant lower extremity DVT in 21%, and pulmonary embolism in 5%. Complete resolution of DVT on follow-up was documented in 46%. Thrombosis resolved in only 25% (6 of 24) when the catheter was not removed (P <or= .05). Anticoagulation did not improve the rate of thrombus resolution (P <or= 1.0) compared with catheter removal alone. Of the patients who had thrombus resolution, 75% resolved by 100 days (range, 1-914 days) after catheter removal <or=48 hours of diagnosis. In multivariate analysis, only catheter removal predicted the likelihood of thrombus resolution (odds ratio, 3.25; 95% confidence interval, 1.16-9.09; P = .025). New-site UEDVT developed in 86% of patients with CAUEDVT who underwent catheter removal and immediate catheter placement in a new site. Pulmonary embolism developed in five patients with CAUEDVT. Of these, three had documented lower extremity DVT as well. No pulmonary emboli were fatal.
More than half of CAUEDVT resolve <or=113 days when the catheter is removed <or=48 hours of diagnosis. New-site catheter placement has a high rate of new associated UEDVT. Anticoagulation does not appear to augment resolution of UEDVT.
导管相关性上肢深静脉血栓形成(CAUEDVT)是众所周知的;然而,CAUEDVT 的溶解率和影响其溶解的因素尚不清楚。本研究旨在确定 CAUEDVT 的溶解率和相关因素。
2002 年 1 月 1 日至 2006 年 6 月 30 日,进行了 1761 例上肢静脉双功超声(DU)检查,发现 253 例(14.4%)新出现 UEDVT。其中,150 例患者进行了常规随访,101 例患者发生了 CAUEDVT。对有随访研究和 CAUEDVT 的患者记录了人口统计学、随访 DU 结果和静脉血栓形成的危险因素。采用单因素分析和多因素逻辑回归分析确定完全血栓溶解的独立危险因素。
CAUEDVT 和随访研究中有 49 例男性(49%)和 52 例女性(51%)。平均年龄为 49 岁(范围,5 个月至 80 岁)。CAUEDVT 患者存在静脉血栓形成的危险因素,包括恶性肿瘤 34%、近期手术/创伤 34%、已知易栓症 11%、同时伴有下肢深静脉血栓形成 21%和肺栓塞 5%。随访发现 46%的 DVT 完全溶解。当导管未取出时,血栓溶解仅为 25%(24 例中的 6 例)(P <or=.05)。与单独导管去除相比,抗凝并不能提高血栓溶解率(P <or= 1.0)。在有血栓溶解的患者中,75%在导管去除后 100 天(范围,1-914 天)内溶解<or=48 小时诊断后。多因素分析显示,只有导管去除预测了血栓溶解的可能性(比值比,3.25;95%置信区间,1.16-9.09;P =.025)。在接受导管去除和立即在新部位放置导管的 CAUEDVT 患者中,86%发生了新部位 UEDVT。5 例 CAUEDVT 患者发生了肺栓塞。其中 3 例有明确的下肢深静脉血栓形成。没有致命的肺栓塞。
当导管在诊断后 48 小时内取出时,超过一半的 CAUEDVT 在<or=113 天内溶解。新部位导管放置的新部位 UEDVT 发生率较高。抗凝似乎并不能促进 UEDVT 的溶解。